Results
|
|
4021.
|
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. [electronic resource] by
- Sinnberg, Tobias
- Lasithiotakis, Konstantinos
- Niessner, Heike
- Schittek, Birgit
- Flaherty, Keith T
- Kulms, Dagmar
- Maczey, Evelyn
- Campos, Minia
- Gogel, Jeannette
- Garbe, Claus
- Meier, Friedegund
Producer: 20090622
In:
The Journal of investigative dermatology vol. 129
Availability: No items available.
|
|
|
4022.
|
|
|
|
4023.
|
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. [electronic resource] by
- Spiegl-Kreinecker, Sabine
- Pirker, Christine
- Filipits, Martin
- Lötsch, Daniela
- Buchroithner, Johanna
- Pichler, Josef
- Silye, Rene
- Weis, Serge
- Micksche, Michael
- Fischer, Johannes
- Berger, Walter
Producer: 20100511
In:
Neuro-oncology vol. 12
Availability: No items available.
|
|
|
4024.
|
|
|
|
4025.
|
|
|
|
4026.
|
|
|
|
4027.
|
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study. [electronic resource] by
- Ahluwalia, Manmeet S
- Xie, Hao
- Dahiya, Saurabh
- Hashemi-Sadraei, Nooshin
- Schiff, David
- Fisher, Paul G
- Chamberlain, Marc C
- Pannullo, Susan
- Newton, Herbert B
- Brewer, Cathy
- Wood, Laura
- Prayson, Richard
- Elson, Paul
- Peereboom, David M
Producer: 20151217
In:
Journal of neuro-oncology vol. 122
Availability: No items available.
|
|
|
4028.
|
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe. [electronic resource] by
- Pérès, Elodie A
- Gérault, Aurélie N
- Valable, Samuel
- Roussel, Simon
- Toutain, Jérôme
- Divoux, Didier
- Guillamo, Jean-Sébastien
- Sanson, Marc
- Bernaudin, Myriam
- Petit, Edwige
Producer: 20151204
In:
Oncotarget vol. 6
Availability: No items available.
|
|
|
4029.
|
|
|
|
4030.
|
|
|
|
4031.
|
Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. [electronic resource] by
- Murai, Junko
- Huang, Shar-Yin N
- Renaud, Amèlie
- Zhang, Yiping
- Ji, Jiuping
- Takeda, Shunichi
- Morris, Joel
- Teicher, Beverly
- Doroshow, James H
- Pommier, Yves
Producer: 20150219
In:
Molecular cancer therapeutics vol. 13
Availability: No items available.
|
|
|
4032.
|
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. [electronic resource] by
- Murphy, Á C
- Weyhenmeyer, B
- Schmid, J
- Kilbride, S M
- Rehm, M
- Huber, H J
- Senft, C
- Weissenberger, J
- Seifert, V
- Dunst, M
- Mittelbronn, M
- Kögel, D
- Prehn, J H M
- Murphy, B M
Producer: 20131023
In:
Cell death & disease vol. 4
Availability: No items available.
|
|
|
4033.
|
|
|
|
4034.
|
MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. [electronic resource] by
- Li, Rui-Yan
- Chen, Ling-Chao
- Zhang, Hai-Yan
- Du, Wen-Zhong
- Feng, Yan
- Wang, Han-Bing
- Wen, Jin-Qiong
- Liu, Xin
- Li, Xian-Feng
- Sun, Ying
- Yang, Dong-Bo
- Jiang, Tao
- Li, Yong-Li
- Jiang, Chuan-Lu
Producer: 20140120
In:
CNS neuroscience & therapeutics vol. 19
Availability: No items available.
|
|
|
4035.
|
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. [electronic resource] by
- Weller, Michael
- Kaulich, Kerstin
- Hentschel, Bettina
- Felsberg, Joerg
- Gramatzki, Dorothee
- Pietsch, Torsten
- Simon, Matthias
- Westphal, Manfred
- Schackert, Gabriele
- Tonn, Joerg C
- von Deimling, Andreas
- Davis, Thomas
- Weiss, William Andrew
- Loeffler, Markus
- Reifenberger, Guido
Producer: 20140514
In:
International journal of cancer vol. 134
Availability: No items available.
|
|
|
4036.
|
Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital. [electronic resource] by
- Diebold, G
- Ducray, F
- Henaine, A-M
- Frappaz, D
- Guyotat, J
- Cartalat-Carel, S
- Breant, V
- Fouquet, A
- Aulagner, G
- Honnorat, J
- Armoiry, X
Producer: 20150626
In:
Journal of clinical pharmacy and therapeutics vol. 39
Availability: No items available.
|
|
|
4037.
|
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. [electronic resource] by
- Liu, Xuesong
- Shi, Yan
- Maag, David X
- Palma, Joann P
- Patterson, Melanie J
- Ellis, Paul A
- Surber, Bruce W
- Ready, Damien B
- Soni, Niru B
- Ladror, Uri S
- Xu, Allison J
- Iyer, Ramesh
- Harlan, John E
- Solomon, Larry R
- Donawho, Cherrie K
- Penning, Thomas D
- Johnson, Eric F
- Shoemaker, Alexander R
Producer: 20120801
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
4038.
|
|
|
|
4039.
|
|
|
|
4040.
|
|